Meharry Medical College and Morehouse School of Medicine: Focusing on Adolescent Health and Empowerment

With support from PEPFAR and the U.S. Centers for Disease Control and Prevention (CDC) partnership, we were honoured to host a site visit to the Chainda South Clinic and Kamwala Health Centre Youth Friendly Rooms (YFR) with Dr James Hildreth, President of the Meharry Medical College and Dr Valerie Montgomery Rice, President of the Morehouse School of Medicine, both in the USA.

The purpose of the visit was to explore how these American Historically Black Colleges and University medical schools can become involved in PEPFAR and CDC-supported programmes in Zambia to specifically address the HIV epidemic amongst adolescents as these are high-risk populations for acquiring HIV and STD infections.

Drs Hildreth and Montgomery Rice are both educationalists and researchers and were very interested to learn more about the CIDRZ youth outreach programmes and how they offer HIV counseling and testing as well as sexual and reproductive health information to adolescents as well as encourage healthy social activities and academic engagement.

Vincent and Maxwell Mumba, trained Peer Educators explained what takes place at the Kamwala YFR, as well as during outreach programmes in communities and churches. “We can test as many as 200 youth during one outreach programme,” they explained.
Dr Montgomery Rice who is also Dean of the Morehouse School of Medicine remarked, “This adolescent programme is clearly impressive. Dr Hildreth and I will see how we can work with the programme to support their activities through an increased use of technology. We will also provide resources and support for career progression for the youth volunteers that are working under this programme.”

During their time in Lusaka the guests also had meetings with the Minister of Health, the Minister of Higher Education, Deans of the Health Sciences divisions at University of Zambia, and PEPFAR and CDC Representatives.

Providing Health Services and Sensitisation at Zambian Traditional Ceremonies

In the photo CIDRZ Senior Community Advisor Mr Fresher Maphiri and MC Community Coordinator Bright Jere meet with his Royal Highness Senior Chief Nacilele of Kaoma at his Royal Palace. Chief Nacilele is an advocate for medical male circumcision and encourages all men in his chiefdom to have the procedure. He says that all seven of his grand sons have been circumcised.

Zambia is blessed with over 70 distinct tribes and many have annual traditional ceremonies that bring throngs of tribesmen together to celebrate their cultural diversity. Events such as these provide an excellent opportunity to reach people with health services, accurate health messages, and dispel misconceptions.

With the support of the US PEPFAR and CDC partnership, CIDRZ community teams attend these events, and recently they traversed the country to provide HIV testing and counselling, and provide information and health messages about medical male circumcision, ART adherence and tuberculosis screening at the Nc’wala Traditional Ceremony of the Ngoni people of Eastern Province, followed by the Kuomboka Traditional Ceremony of the Lozi speaking people of Western Province.  Over 2000 people received HIV testing and counselling at these two events, and interested men were booked for medical circumcision at the nearest health facilities offering the service.

After the Kuomboka Traditional Ceremony, the CIDRZ team also were privileged to meet with six of the local Lozi traditional leaders, or their representatives, to seek the intervention of the Royal Highnesses to assist in increasing the uptake of health services, particularly of HIV testing, male circumcision (MC) and antiretroviral therapy (ART) adherence, amongst their people.

In addition to meeting with the KUTA, full cabinet of the Lozi Paramount Chief, the Litunga; they visited the Chiefs in Senanga, Kalabo, Mongu, Limulunga and Kaoma.

Construction of Nachitete Mini Hospital Gives Hope to Chongwe Community


Over the years, I have donated land for the construction of various government institutions including the Chongwe District Hospital and schools. All these have been done after seeing the need and demand for the critical services in my chiefdom,” expressed Her Royal Highness Senior Chieftainess Nkomeshya Mukamambo II.

The Nachiteti Mini Hospital

Our healthcare system must be effective, efficient, accessible, acceptable, equitable and safe to deliver quality service that improves patient outcomes.” Minister of Health, Hon. Dr. Chitalu Chilufya as he officially commissioned the health facility.

The facility was upgraded by the Zambian government. Speaking during the  event, Lusaka Provincial Minister, Hon. Japhen Mwakalombe said “the most vulnerable people who are in most cases – women and children – especially in rural areas, need well-designed healthcare and education systems closer to their households. This will not only make their lives better, but it will also encourage them to seek early medical care whenever they need it.

With support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR) and the CDC partnership, CIDRZ is proud to have been part of the official opening of the Nachitete Mini Hospital in Chongwe District where we were on-site to provide HIV testing and counselling, and screening for cervical cancer.

In addition, CIDRZ will continue to provide HIV testing and counselling, Voluntary Medical Male Circumcision, and support the Option B Plus programme for HIV-positive pregnant or breastfeeding women offering them life-long antiretroviral treatment (ART). At the event we reiterated our commitment to work with the health facility to provide quality health services to the Nachitete area, including parts of Lusaka and Chilanga Districts which previously used to access services from other distant facilities. CIDRZ will continue to support and and strengthen the health system to ensure that the clinic becomes one of the ART centres in the District.

CIDRZ Joins the HIV Coverage, Quality and Impact Network (CQUIN) Learning Network

Dr Sikazwe fourth from left on the panel “Implementing Differentiated Care: Innovations and Challenges”

Last week CIDRZ CEO Dr Izukanji Sikazwe attended the HIV Coverage, Quality and Impact (CQUIN) Learning Network meeting Partnering to Advance Differentiated Care in Umhlanga, South Africa  The event was supported by the Columbia University, Mailman School of Public Health ICAP program and the keynote address was delivered by the ICAP Global Director, Dr Wafaa El-Sadr. The participating countries of South Africa, Zambia, Kenya, Mozambique, Zimbabwe, Swaziland, and Malawi were represented by members of their Ministries of Health, national AIDS program and other key stakeholders. Dr Sikazwe sat on the panel “Implementing Differentiated Care: Innovations and Challenges” as well as presenting a Zambia country update about our CIDRZ experience. CIDRZ is currently conducting a differentiated care implementation study called Community ART for Retention in Zambia or “Community ART” with grant support from the Bill & Melinda Gates Foundation. Other Zambia representatives were: Dr Bridget Mugisa, CDC Branch Chief Care and Treatment, Dr Ignace Gashongore University of Maryland Chief of Party, Dr Daniel Makawa Deputy Director Clinical Care Ministry of Health, Theresa Sikateyo Country Director ICAP, and Angela Taylor, Acting Country Director Equip.

The purpose of CQUIN is to foster a learning network of countries interested in partnering to enhance and accelerate the implementation of high-quality differentiated service delivery for HIV. The ultimate goal is to increase the number of people living with HIV initiating and sustaining highly effective HIV treatment with sustained viral suppression.




Call for Abstracts: 36th Annual Pharmacy Scientific Conference: Shifting Paradigms Towards Pharmaceutical Research in Disease Prevention and Anti-Microbial Resistance

CALL FOR ABSTRACTS : 36th Annual Pharmacy Scientific Conference
SUBMISSION DEADLINE: 12 May 2017  23:59 Central Africa Time

36th Annual Pharmacy Scientific Conference
Theme: Shifting Paradigms Towards Pharmaceutical Research in Disease Prevention and Anti-Microbial Resistance
15-16 June 2017
Chrismar Hotel
Livingstone, Zambia

The Annual Pharmacy Scientific Conference enables dissemination of current, original pharmaceutical research and practice that introduces new ideas, concepts and understanding in the these four sub-themes:

  • Pharmaceutical Technology and Innovation 
  • Disease Prevention and Health Promotion
  • Rationale Use of Medicine
  • Pharmaceutical Practice and Policy

The Pharmaceutical Society of Zambia Journal Committee and the Conference Editorial Committee will review submitted abstracts and evaluate them based on the following criteria:

 – Direct relevance to the selected sub-theme
 – Scientific merit
 – Submission of a clearly written, well organized and structured abstract

Abstracts should be no more than 500 words and should concisely describe:

 – Background
 – Aims/Objectives
 – Methodology
 – Results/Findings
 – Conclusion(s)


Submission Deadline: 11:59 pm CAT   on  May 12, 2017
Please do not submit an abstract if you are not confident that you will be able to attend the conference and make the presentation.


– All abstracts should be in English.
– Incomplete or inaccurate abstracts will be rejected.
– Each attendee may present no more than two abstracts.
– Presenting an abstract is a voluntary effort and attendees will not be paid to present.
Abstract acceptances will apply only to the presenting author. Acceptances are not transferable to co-authors.


Only capitalize the first word, the word following a colon, and all proper nouns and adjectives as shown in the example below. Italicize Latin species names.

Example: Combating antimicrobial resistance (AMR) through improved rational drug use in Chongwe District”

  • The first word of the title should not be A,  An, or The.
  • Spell out acronyms and symbols such as equal, plus and minus.
  • Do NOT use brand names of medications or other products in the title
  • Abbreviations may be used in the title, provided the name in full is outlined in the body of the abstract.

A concise statement of no more than 500 words describing the:

Background, Aims/Objectives, Methodology, Results/Findings and Conclusion(s)

– Arial, 12pt font, single-spaced and left aligned.
– DO NOT use all caps.
 – Use standard abbreviations only.
– Spell out a proper name in full at the first mention, followed by the abbreviation in parenthesis.
– The abstract title, author names, affiliations and references are not included in the 500 word limit.
– Include no more than five key words in a separate line at of your abstract.

To Submit Your Abstract:

Email it to BOTH:     and 

In the subject line:
– Write the Title of your abstract

In the body of your email include in this order:
– Specific sub-theme
– Oral, or Poster presentation
– Abstract Title
– Presenting Author, institutional affiliation, contact details, including email
– Name and Organisation of Co-Authors in the order they should appear in the Abstract book
– Brief biography (no more than 50 words) of the Presenting Author

If after you have submitted your abstract you choose to withdraw your submission, email     and and type WITHDRAWN and the Title of your abstract in the subject line.


Abstract Evaluation Process and Criteria:

The Pharmaceutical Society of Zambia Journal Committee and the Conference Editorial Committee will review the abstracts based on the following criteria:

  • Direct relevance to the selected sub-theme
  • Scientific merit
  • Submission of a clearly written, well organized and structured abstract
  • Strict adherence to the submission guidelines outlined above

The Committee will notify authors with formal acceptance or rejection notices sent to the email address provided during the abstract submission process.

Note: If your abstract is accepted, the Committee will indicate if it will be an oral presentation or poster.

Dissemination of Abstracts:

Accepted abstracts will be published in the Pharmaceutical Journal of Zambia, June 2017 Edition [ISSN-2520-4327 (Print)] and disseminated to all conference attendees in print format.